Features of pregnancy management and prevention of complications in patients with SLE
Автор: Chidigova R.B., Yandarova R.A., Parshoeva B.Sh., Zavarzin D.Yu.
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 30, 2024 года.
Бесплатный доступ
The article discusses the features of pregnancy management and prevention of complications in patients with systemic lupus erythematosus. The authors note that pregnancy outcomes in patients with SLE are improving due to medical advances; however, pregnancy caused by lupus is still associated with a large number of maternal and fetal complications compared to healthy women. The frequency of exacerbations of lupus during pregnancy is high, and with SLE, the frequency of fetal loss, premature birth and the birth of newborns with a body weight deficit increases. Early prediction of possible complications is necessary to improve maternal and neonatal outcomes. The authors determined that in most cases, bearing children by women with a history of SLE brings favorable results. Consul-tations during the prenatal period, adequate interdisciplinary supervision and optimal processing of fundamental procedures allow us to achieve good results.
Pregnancy, systemic lupus erythematosus, complications, prevention
Короткий адрес: https://sciup.org/148328276
IDR: 148328276 | DOI: 10.18137/cardiometry.2024.30.98102
Список литературы Features of pregnancy management and prevention of complications in patients with SLE
- Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome. N. Engl. J. Med. 2018; 378:2010-21.
- Walter IJ, et al. Pregnancy outcome predictors in antiphospholipid syndrome: A systematic review and meta-analysis. Autoimmun. Rev. 2021;20:102901.
- Plantone D, Koudriavtseva T. Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. Clin. Drug. Investig. 2018;38:653–71.
- Duan J, et al. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis. Lupus. 2021;30:1163–74.
- Tian Y, et al. The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: A systematic review and meta-analysis. J. Gynecol. Obstet. Hum. Reprod. 2021;50:102-21.
- Page MJ, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372(71).
- Do SC, et al. Does Hydroxychloroquine Protect against Preeclampsia and Preterm Delivery in Systemic Lupus Erythematosus Pregnancies? Am. J. Perinatol. 2020;37:873–80.
- Liu Y, et al. Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: A propensity scorematched analysis and meta-analysis. Arch. Gynecol. Obstet. 2021;303:435–41.
- Gerde M, et al. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thromb. Res. 2021;206:104–10.
- Canti V, et al. Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine. Immunol. Med. 2021;44:204-10.
- Negrini S, et al. The antiphospholipid syndrome: From pathophysiology to treatment. Clin. Exp. Med. 2017; 17:257–67.
- Hwang JK, et al. Maternal outcomes and follow-up of premature and full-term newborns born to mothers with systemic lupus erythematosus. J Matern Fetal Neonatal Med. 2018;31(01):7–13
- Bundhun PK, Soogund MZ, Huang F. The effect of systemic lupus erythematosus on maternal and fetal outcomes after pregnancy: a meta-analysis of studies published between 2001 and 2016. J. Autoimmune 2017; 79: 17-27
- Yamamoto Yu, Aoki S. Systemic lupus erythematosus: strategies for improving pregnancy outcomes. Int J Women’s health. 2016; 8: 265-272
- Lightstone L, Khladunevich MA. Lupus nephritis and pregnancy: problems and treatment Semin Nefrol. 2017; 37(4):347-53.
- Wu J, et al. Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis Ther Clin Risk Manag. 2018; 14: 885-901.
- Knight KL, Nelson-Piercy K. Treatment of systemic lupus erythematosus during pregnancy: problems and solutions Open Access Rheumatol. 2017; 9:37-53.
- L Andreoli, et al. EULAR recommendations on women’s health and family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Ann Reum Dis. 2017;76(3).
- L Keenan, et al. A systematic review of hormonal contraception and the risk of venous thrombosis Linacre K. 2018;85(4):470-7.
- KH Dao, BL Bermas. Treatment of systemic lupus erythematosus during pregnancy Int J Women’s Health. 2022;14:199-211.
- Close MB, et al. Hydroxychloroquine in pregnancy in women with lupus: a meta-analysis of data from individual participants Lupus Sci Med. 2022;9(1).
- McMaster KM, et al. A systematic review and meta-analysis of hypocalciuria in preeclampsia Int J Gynaecol Obstet. 2017;138(1):3-11.
- Quenby S, et al. Miscarriage matters: the epidemiological, physical, psychological and economic costs of early pregnancy loss. Lancet. 2021;397:1658-67.
- Ayres de Campos D, Spong California, Chandraharan E. FIGO’s agreed recommendations for fetal monitoring during childbirth: Cardiotocography. Interj. J. Gynecol. It will be fine. 2015;131:13-24.
- Tang Yu, et al. Complications of systemic lupus erythematosus associated with pregnancy. J Autoimmune. 2022; 132:102864